diphtheria, tetanus, pertussis (acellular), poliomyelitis (inactivated), hepatitis b (rDNA) and haemophilus influenzae type b (Hib) vaccine · Medicine question

Is evaluation of pharmacokinetic properties required for Infanrix hexa?

Name: Is evaluation of pharmacokinetic properties required for Infanrix hexa?
Published: 2026-11-08T13:48:30.361Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

No, evaluation of pharmacokinetic properties is not required for Infanrix hexa because it is a vaccine.

Sources for this answer

Infanrix hexa, Powder and suspension for suspension for injectionGlaxoSmithKline UK · emc · SmPC §5.2 Pharmacokinetic properties · Version 13Document updated 7 April 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about diphtheria, tetanus, pertussis (acellular), poliomyelitis (inactivated), hepatitis b (rDNA) and haemophilus influenzae type b (Hib) vaccine